Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
187 studies found for:    amenorrhea
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea
Condition: Amenorrhea
Interventions: Drug: DR-2021a;   Drug: DR-2021b;   Drug: DR-2021c;   Drug: DR-2021d;   Drug: DR-2021e;   Other: Placebo
2 Active, not recruiting Study of Leptin for the Treatment of Hypothalamic Amenorrhea
Condition: Amenorrhea
Interventions: Drug: r-metHuLeptin;   Drug: Oral Contraceptive Pills (OCPs)
3 Recruiting Total Antioxidant Capacity Before and After HRT in Hypotalamic Amenorrhea
Condition: Hypothalamic Amenorrhea
Intervention: Drug: 1 mg of transdermal estradiol daily and 10mg of oral MPA
4 Withdrawn Efficacy and Safety of Metformin in Preventing Patients With Risperidone From Weight Gain and Amenorrhea
Conditions: Weight Gain;   Amenorrhea
Interventions: Drug: Metformin;   Other: Starch tablets
5 Completed Metformin for Treatment Antipsychotic Induced Amenorrhea in Female Schizophrenic Patients
Condition: Amenorrhea
Intervention: Drug: metformin
6 Recruiting The Effect of Post Ablation Medroxyprogesterone Acetate on Endometrial Amenorrhea Rates
Condition: Menorrhagia
Interventions: Drug: MPA;   Drug: placebo
7 Completed Descriptive, Prospective, Non-interventional Study (NIS) to Describe Mirena and Amenorrhea Related Acceptability in Contraception Indication in Medical Practice
Condition: Female Contraception
Intervention: Drug: Levonorgestrel IUD (Mirena, BAY86-5028)
8 Unknown  Emergency Contraception as a Back up of Lactational Amenorrhea Method(LAM)
Conditions: Pregnancy During Breastfeeding;   Lactational Amenorrhea Method
Intervention: Drug: Counseling for LAM+ LNG-EC
9 Terminated A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding for Secondary Amenorrhea
Condition: Secondary Amenorrhea
Intervention: Drug: Progesterone
10 Not yet recruiting Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea
Conditions: Breast Cancer;   Chemotherapy Induced Amenorrhea;   Ovarian Function Suppression
Interventions: Drug: Goserelin;   Drug: Toremifene
11 Not yet recruiting Psychological Impact of Amenorrhea in Women With Endometriosis
Conditions: Amenorrhea;   Endometriosis;   Quality of Life
Interventions: Drug: Estroprogestinic therapy (Etinil-estradiol/levonorgestre);   Drug: Gonadotropin-releasing hormone agonist (Leuprorelin acetate);   Drug: Add back therapy 1 (tibolone);   Drug: Add back therapy 2 (calcium carbonate/colecalciferol)
12 Completed
Has Results
Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory Conversion
Condition: Secondary Amenorrhea
Interventions: Drug: PROMETRIUM® 300 mg;   Drug: PROMETRIUM® 400 mg
13 Completed Hormone Dynamics and Bone Mineral Density in Anorexia Nervosa v. Hypothalamic Amenorrhea
Conditions: Anorexia Nervosa;   Hypothalamic Amenorrhea;   Obesity
Intervention:
14 Completed Pathogenesis of Functional Hypothalamic Amenorrhea
Conditions: Disorder of Endocrine Ovary;   Hypersecretion; Cortisol;   Metabolic Disturbance;   Stress, Psychological
Intervention: Behavioral: Cognitive behavior therapy
15 Recruiting Ultrasound Characterization of Ovarian Follicle Dynamics in Women With Amenorrhea
Conditions: Oligomenorrhea;   Amenorrhea;   Polycystic Ovary Syndrome (PCOS)
Intervention:
16 Completed Efficacy of Mifepristone - Prostaglandin Analogue Combination in Medical Termination of Pregnancy Beyond 7 Weeks of Amenorrhea
Condition: Medical Termination of Pregnancy
Intervention:
17 Recruiting LutrePulse Hypogonadotropic Hypogonadism
Condition: Primary Amenorrhea With Hypogonadotropic Hypogonadism
Interventions: Drug: Gonadorelin acetate 10µg/pulse;   Drug: Gonadorelin acetate 15µg/pulse;   Drug: Gonadorelin acetate 20µg/pulse;   Drug: Placebo
18 Completed
Has Results
Determination of the Lowest, Safe and Effective Dose of Proellex
Condition: Amenorrhea
Intervention: Drug: Proellex
19 Recruiting The Cycle Disturbances, OLigomenorrhea and Amenorrhea (COLA) Study & Biobank
Condition: Anovulation
Intervention:
20 Active, not recruiting Menstrual Cycle Maintenance and Quality of Life: A Prospective Study
Conditions: Amenorrhea;   Menstrual Cycle;   Breast Cancer
Intervention: Other: Questionnaire

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.